As part of the Inflation Reduction Act, manufacturers are required to pay a rebate to Medicare if a drug's price increase exceeds the rate of inflation. CMS said it intends to send the first invoices ...

Ozempic and Wegovy are among the 15 additional drugs selected for a list that will be negotiated for lower Medicare prices. Ten other drugs have already been selected for the Medicare list in an ...

The Medicare drug list, also called a formulary, lists the prescription drugs and vaccines that Medicare covers. Medicare provides this coverage through Medicare Part D or Medicare Advantage (also ...

(The Hill) – The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug Price Negotiation Program, including the high-cost medications ...

The federal government announced the next 15 medicines for which it will seek price reductions with the help of Medicare’s new negotiating power, including the breast cancer drugs Kisqali and Verzenio ...

Medicare announced Friday that it has selected 15 drugs, including the hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, as well as some blockbuster cancer medications ...

WASHINGTON -- Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be negotiated directly between the government and drug ...

While the 15 medications selected for the latest round of the federal government’s drug price negotiation program will face steep cuts in what Medicare will pay, the financial impact to pharmaceutical ...